Viral Clearance, PK and Tolerability of Ensovibep in COVID-19 Patients
NCT04834856
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Covid19
Interventions
DRUG:
ensovibep
Sponsor
Molecular Partners AG